Barriers to export by Wells, William A.
 
In This Issue 689
 
T
 
EXT
 
 B
 
Y
 
 W
 
ILLIAM
 
 A. W
 
ELLS
WELLSW
 
@
 
ROCKEFELLER
 
.
 
EDU
 
A disease of actin 
transport?
 
pinal muscular atrophy (SMA), a 
motoneuron disease that results in 
paralysis and death usually before age 3, 
is caused by loss of the 
 
SMN1
 
 gene. But 
what does the established splicing function 
of SMN1 have to do with motoneurons? 
Perhaps very little, say Rossoll et al., who 
on page 801 show that SMN1 is part of
a complex that drags 
 
 
 
-actin mRNA out 
to growth cones so that axons can grow 
and possibly function properly.
The authors first looked at motoneuron 
survival in vitro. Survival of cells from a 
mouse SMA model was unimpaired, but 
axon growth, growth cone size, and axonal 
accumulation of actin was reduced. The 
SMN protein has been shown to associate 
with the RNA-binding protein hRNP R, 
and Rossoll et al. found that hRNP R 
associates, in turn, with 
 
 
 
-actin mRNA. 
The axonal concentration of both hRNP 
R and 
 
 
 
-actin mRNA are lost in cells 
lacking SMN1.
Individuals with SMA apparently live 
as long as they do because full-length 
SMN2 can carry out at least part of the 
essential splicing function of SMN 
proteins. But most SMN2 transcripts 
have a small deletion relative to SMN1, 
and thus are inactive in both splicing and 
axon localization functions. It is not yet 
clear if the localization function is the sole 
determinant of SMA disease, and if it 
is needed for transport of mRNAs other 
than 
 
 
 
-actin mRNA. But at least in theory 
the shortage of axonal actin could lead to 
deficits not just in axonal outgrowth but 
also in synaptic functioning. One distant 
option for correcting these defects might 
be to boost the activity of an mRNA 
transport component.
 
 
 
 
S
SMA neurons (right) have less actin.
 
Notch gets transformed
 
ells exist in complicated environments filled with
reinforcing and conflicting signals. Three recent
papers (Blokzijl et al., page 723; Takizawa et al.,
2003. 
 
Nucl. Acids. Res.
 
 31:5723–5731; Dahlqvist et
al., 2003. 
 
Development
 
. 10.1242/dev.00834) describe
a link between pathways downstream of two of the
most important of these signals: Notch and the
TGF-
 
 
 
/BMP systems.
Both signaling pathways trigger the release of initially
receptor-localized species—the Notch intracellular
domain (NICD) and the Smads, respectively—that
C
TGF-  signaling (blue) 
requires Notch cooperation. 
 
then enter the nucleus. And recent microarray results suggested that both pathways
converge on at least one common target gene. Now, Blokzijl et al. demonstrate that
Notch and Smad3 (a protein released from the transforming growth factor 
 
 
 
 (TGF-
 
 
 
)
receptor after ligand binding) bind each other, and then bind and activate a target
promoter. The other two papers describe a similar association between Notch and
Smad1 (which is downstream of the bone morphogenetic protein [BMP] receptor)
that is enhanced by binding of coactivators (Takizawa et al.) and required for a BMP4-
mediated block of muscle differentiation (Dahlqvist et al.).
Such a requirement for two signals could be seen as further reducing the choices
available for developmental processes, which use and reuse a limited number of
signaling pathways. But senior author Carlos Ibáñez sees the new complexes as
the cell’s equivalent of a computational AND gate, and anticipates that a closer
investigation of signaling complexes will show that the complexes work like small
microprocessors. Only with such integration, he says, can cells deal with all the
complexity that surrounds them. 
 
 
 
Barriers to export
 
uclear pores facilitate transport into and out of the nucleus. But now Roth 
et al. report that cells with more of the nucleoporin DNup88 do less nuclear 
export (page 701). DNup88 exerts this negative effect by sequestering the 
exportin DCRM1 so that it can no longer do its job.
Roth et al. first established that cells with DNup88 were compromised for 
nuclear export but not import. The overactive export in cells lacking DNup88 
could be prevented by inhibiting DCRM1, which shuttles its cargos out of the 
nucleus. DNup88, DCRM1, and the nucleoporin DNup214 are normally found 
in a complex on the cytoplasmic face of the nuclear pore, but loss of DNup88 
frees up DCRM1 so that it can enter the nucleus and help export more proteins.
The authors found a correlation between DNup88 levels and the effectiveness 
of nuclear export at different stages of fly development. Such alterations of 
DNup88 levels may be one way of altering the rates of export of many substrates, 
N
 
rather than tweaking the binding 
of individual substrates to 
DCRM1 by, for example, phos-
phorylation. But Roth et al. are 
also on the lookout for phosphor-
ylations or other modifications 
of the DNup88/DCRM1 system 
that may alter export capability 
in response to specific signals. 
 
 
Loss of a Nup (right) leads to excessive nuclear 
export.
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